Cargando…

MiT/TFE Family Renal Cell Carcinoma

The microphthalmia-associated transcription factor/transcription factor E (MiT/TFE) family of transcription factors are evolutionarily conserved, basic helix–loop–helix leucine zipper (bHLH-Zip) transcription factors, consisting of MITF, TFEB, TFE3, and TFEC. MiT/TFE proteins, with the exception of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jinglong, Baba, Masaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859458/ https://www.ncbi.nlm.nih.gov/pubmed/36672892 http://dx.doi.org/10.3390/genes14010151

Ejemplares similares

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Emerging roles and regulation of MiT/TFE transcriptional factors
por: Yang, Min, et al.
Publicado: (2018)

MiT/TFE Family of Transcription Factors: An Evolutionary Perspective
por: La Spina, Martina, et al.
Publicado: (2021)

Dissection of tumor-intrinsic and tumor-extrinsic features of MiT/TFE translocation renal cell carcinoma via single-cell RNA sequencing
por: Konda, Prathyusha, et al.
Publicado: (2023)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022)

MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5
por: Nezich, Catherine L., et al.
Publicado: (2015)

MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat
por: Annunziata, Ida, et al.
Publicado: (2019)

Racial Disparities in MiT Family Translocation Renal Cell Carcinoma
por: Lu, Xiaofan, et al.
Publicado: (2023)

Proteogenomic characterization of MiT family translocation renal cell carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2022)

MiT/TFE factors control ER‐phagy via transcriptional regulation of FAM134B
por: Cinque, Laura, et al.
Publicado: (2020)

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
por: Caliò, Anna, et al.
Publicado: (2019)

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
por: Thouvenin, Jonathan, et al.
Publicado: (2022)

RagD auto-activating mutations impair MiT/TFE activity in kidney tubulopathy and cardiomyopathy syndrome
por: Sambri, Irene, et al.
Publicado: (2023)

HEPES activates a MiT/TFE-dependent lysosomal-autophagic gene network in cultured cells: A call for caution
por: Tol, Marc J., et al.
Publicado: (2018)

LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
por: Yadavalli, Narayana, et al.
Publicado: (2023)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

Structural basis for FLCN RagC GAP activation in MiT-TFE substrate-selective mTORC1 regulation
por: Jansen, Rachel M., et al.
Publicado: (2022)

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
por: Aldera, Alessandro Pietro, et al.
Publicado: (2022)

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
por: Alhalabi, Omar, et al.
Publicado: (2023)

MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report
por: Yang, Kaihang, et al.
Publicado: (2023)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma
por: Wang, Haili, et al.
Publicado: (2018)

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017)

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma
por: Lin, Junyi, et al.
Publicado: (2023)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
por: Chacko, Arman Z., et al.
Publicado: (2023)

Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling
por: Calcagnì, Alessia, et al.
Publicado: (2016)

TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022)

Case Report: A MiT family translocation renal cell carcinoma in the renal pelvis, calyces and upper ureter misdiagnosed as upper tract urothelial carcinoma
por: Zou, Yuhua, et al.
Publicado: (2023)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

TFE3‐PD‐L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma
por: Guo, Xudong, et al.
Publicado: (2020)

MiT Family Transcriptional Factors in Immune Cell Functions
por: Kim, Seongryong, et al.
Publicado: (2021)

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
por: Murakami, Sho, et al.
Publicado: (2023)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway
por: Li, Luchao, et al.
Publicado: (2021)

Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3
por: Ju, Xiang, et al.
Publicado: (2020)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization
por: Hong, Seung-Beom, et al.
Publicado: (2010)

NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells
por: Zhuang, Wenyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9frljq9e39d9vgcruk04mosoco